Fennec Pharmaceuticals Inc (FRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 800 | N/A | N/A | N/A | N/A |
| Accounts receivable | -7,873 | -7,269 | -1,545 | N/A | N/A |
| Accounts payable and accrued liabilities | -537 | 1,388 | 1,612 | -794 | -41 |
| Other Working Capital | 16,943 | -6,778 | 1,103 | -932 | -763 |
| Other Operating Activity | 17,647 | -4,484 | -19,228 | -12,496 | -14,791 |
| Operating Cash Flow | $26,980 | $-17,143 | $-18,058 | $-14,222 | $-15,595 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,997 | 24,935 | 5,000 | N/A |
| Debt Repayment | -13,000 | 0 | -5,000 | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 0 | 31,967 |
| Other Financing Activity | -615 | 1,641 | 797 | -22 | 322 |
| Financing Cash Flow | $-13,615 | $6,638 | $20,732 | $4,978 | $32,289 |
| Beginning Cash Position | 13,269 | 23,774 | 21,100 | 30,344 | 13,650 |
| End Cash Position | 26,634 | 13,269 | 23,774 | 21,100 | 30,344 |
| Net Cash Flow | $13,365 | $-10,505 | $2,674 | $-9,244 | $16,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | 26,980 | -17,143 | -18,058 | -14,222 | -15,595 |
| Free Cash Flow | 26,980 | -17,143 | -18,058 | -14,222 | -15,595 |